Jeff Yass’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-38,000
Closed -$667K 12983
2024
Q3
$667K Sell
38,000
-9,600
-20% -$164K ﹤0.01% 7787
2024
Q2
$533K Buy
47,600
+19,100
+67% +$180K ﹤0.01% 8123
2024
Q1
$248K Sell
28,500
-3,800
-12% -$34.9K ﹤0.01% 10133
2023
Q4
$395K Buy
+32,300
New +$224K ﹤0.01% 9213
2023
Q1
Sell
-86,700
Closed -$240K 13265
2022
Q4
$240K Buy
+86,700
New +$195K ﹤0.01% 9665
2021
Q4
Sell
-10,900
Closed -$235K 13725
2021
Q3
$235K Buy
+10,900
New +$235K ﹤0.01% 11140
2021
Q2
Sell
-15,100
Closed -$358K 13096
2021
Q1
$358K Buy
15,100
+2,900
+24% +$86.7K ﹤0.01% 10236
2020
Q4
$291K Buy
+12,200
New +$194K ﹤0.01% 9321
2018
Q3
Sell
-12,100
Closed -$183K 10001
2018
Q2
$183K Sell
12,100
-7,600
-39% -$129K ﹤0.01% 8693
2018
Q1
$267K Sell
19,700
-70,300
-78% -$1.33M ﹤0.01% 7820
2017
Q4
$2.12M Sell
90,000
-2,400
-3% -$56.6K ﹤0.01% 3805
2017
Q3
$1.72M Buy
+92,400
New +$2.1M ﹤0.01% 4186

Other funds holding PLSE

Jeff Yass's PLSE Position: Q2 2026 in Review

Jeff Yass sold out of Pulse Biosciences (PLSE) in Q2 2026, closing a stake of 13,411 shares — an estimated $316K sold.

Jeff Yass first reported a position in PLSE in Q1 2018 and held it in 13 quarters. The position peaked at $696K in Q1 2021. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Jeff Yass reported no remaining Pulse Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 13,411 Pulse Biosciences shares in Q2 2026, an estimated $316K.
  • Jeff Yass first reported a position in Pulse Biosciences in Q1 2018 and held it in 13 quarters.
  • Jeff Yass's Pulse Biosciences position peaked at $696K in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.